Skip to content
DefDex

Federal award

OKINAWA MEDIX K.K.

SPE8EQ22D0001

Contract vehicle (IDV)IDV: ceiling is not spending

Obligated and Ceiling

Obligated (net)
$0.00
Vehicle ceiling (not spending)
$574,204.95
Current value
—
Gross positive obligations
$0.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
OKINAWA MEDIX K.K. · R4UGSR3SZFE8
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
OKINAWA MEDIX K.K. · R4UGSR3SZFE8
Awarding agency
Department of Defense · sub-agency 97AS · office SPE8EQ
Funding agency
Department of Defense · sub-agency 97AS
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
SPE8EQ22D0001
Award type code
B
Actions
12 · Nov 23, 2021 to Nov 29, 2024
Why it is listed
contract vehicle (IDV)

Open this award on USAspending →

Action History12

Award actions
DateFYModAction typeObligationCompany in company totals
Nov 29, 2024FY2025P00012B$0.00
—
Feb 1, 2024FY2024P00010D$0.00
—
Nov 27, 2023FY2024P00009M$0.00
—
Jun 29, 2023FY2023P00008M$0.00
—
Nov 28, 2022FY2023P00007M$0.00
—
Nov 10, 2022FY2023P00006M$0.00
—
Sep 13, 2022FY2022P00005B$0.00
—
Aug 17, 2022FY2022P00004M$0.00
—
Dec 15, 2021FY2022P00002B$0.00
—
Dec 15, 2021FY2022P00001B$0.00
—
Dec 15, 2021FY2022P00003M$0.00
—
Nov 23, 2021FY20220—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.